SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-022589
Filing Date
2021-04-30
Accepted
2021-04-30 16:57:29
Documents
10
Period of Report
2021-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A acad-def14a_20210622.htm DEF 14A 2629844
2 GRAPHIC gngxrtcvryjv000068.jpg GRAPHIC 3036
3 GRAPHIC gngxrtcvryjv000002.jpg GRAPHIC 11677
4 GRAPHIC gngxrtcvryjv000023.jpg GRAPHIC 29106
5 GRAPHIC gngxrtcvryjv000026.jpg GRAPHIC 11816
6 GRAPHIC gngxrtcvryjv000024.jpg GRAPHIC 4899
7 GRAPHIC gngxrtcvryjv000001.jpg GRAPHIC 2607
8 GRAPHIC gngxrtcvryjv000071.jpg GRAPHIC 92343
9 GRAPHIC gngxrtcvryjv000070.jpg GRAPHIC 75969
10 GRAPHIC gngxrtcvryjv000037.jpg GRAPHIC 20298
  Complete submission text file 0001564590-21-022589.txt   2978986
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50768 | Film No.: 21879231
SIC: 2834 Pharmaceutical Preparations